NEW DELHI: More than 20.55 lakh COVID-19 tests were conducted in a span of 24 hours, the highest-ever conducted in a single day in India, while the daily positivity rate stands at 13.44 per cent, the Union Health Ministry said on Thursday.
Cumulatively, 20,55,010 tests were conducted on Wednesday in the country. India”s daily COVID-19 recoveries outnumbered the daily new cases for the seventh consecutive day. A total of 3,69,077 patients recuperated in a span of 24 hours as against 2,76,110 infections being reported during the same period, the ministry said. India”s cumulative recoveries have reached 2,23,55,440. Besides India recorded less than 3 lakh new cases for four consecutive days now. Tamil Nadu, Karnataka, Maharashtra, Kerala, Andhra Pradesh, West Bengal,Odisha, Rajasthan, Uttar Pradesh and Hayana reported 77.17 per cent of the 2,76,110 new cases registered in a span of 24 hours.
Tamil Nadu has reported the highest daily new cases at 34,875, followed by Karnataka with 34,281 new cases. The ministry said India”s total active cases have decreased to 31,29,878 with a decline of 96,841 cases being registered in the total active caseload in a day. It now comprises 12.14 per cent of the country”s total cases. Karnataka, Maharashtra, Kerala, Tamil Nadu, Andhra Pradesh, Rajasthan, West Bengal and Uttar Pradesh cumulatively account for 69.23 per cent of India”s total active cases. The National Mortality Rate currently stands at 1.11 per cent, the ministry said. A total of 3,874 deaths were reported in a span of 24 hours. Ten states account for 72.25 per cent of the new deaths. Maharashtra saw the maximum casualties (594). Karnataka follows with 468 daily deaths.
The ministry also said that the cumulative number of COVID-19 vaccine doses administered in the country has reached 18.70 crore. A total of 18,70,09,792 vaccine doses have been administered through 27,31,435 sessions, according to the provisional report till 7 am. These include 96,85,934 healthcare workers (HCWs)) who have taken the first dose and 66,67,394 HCWs who have taken the second dose, 1,46,36,501 FLWs who have received the first dose, 82,56,381 FLWs who have taken the second dose and 70,17,189 beneficiaries in the 18-44 years age group who have received the first dose.
Besides, 5,83,47,950 and 94,36,168 beneficiaries aged 45 to 60 years have been administered the first and second dose respectively, while 5,49,36,096 and 1,80,26,179 beneficiaries of more than 60 years old have taken the first and second dose.
